CE Showcase: Identifying & Improving the Management of Pre-Malignant Lesions with Dr. Miriam Rosin

Dr. Miriam Rosin, Senior Scientist at the BC Cancer Agency, speaks with Dr. John O’Keefe about the importance of developing biomarkers not only for early detection of oral cancer, but also to determine cancerous and non-canderous lesionsand decide adequate subsequent treatment.

Dr. Miriam Rosin is co-leading a session in the Global Oral Cancer Forum 2016, which will take place on March 4-5, at the New York University’s Kimmel Center, in New York City. It evolves around: Challenges in the Global Burden of Oral Cancer: Progress in Early Diagnosis and Prevention.

This inaugural forum will highlight gaps and innovations in prevention, patient care, technology, and services across the oral cancer continuum. International speakers, panelists, and delegates will convene to share the issues they face, and learn about innovations, models, or ideas that have the potential to catalyze positive change globally and help to reduce these statistics.